Anderson Schock
Stock Analyst at B. Riley Securities
(3.80)
# 1,905
Out of 4,966 analysts
42
Total ratings
56.8%
Success rate
13.5%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VREX Varex Imaging | Downgraded: Hold | $18 → $19 | $18.49 | +2.25% | 5 | Aug 10, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $10 → $8 | $3.05 | +162.30% | 2 | Aug 6, 2026 | |
| INFU InfuSystem Holdings | Rated: Buy | $12 → $20 | $12.15 | +64.61% | 3 | Aug 5, 2026 | |
| XGN Exagen | Rated: Buy | $8 → $12 | $7.03 | +70.70% | 5 | Aug 5, 2026 | |
| ANIK Anika Therapeutics | Reiterated: Buy | $18 → $21 | $20.99 | +0.07% | 4 | Jul 30, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $290 | $200.24 | +44.83% | 1 | Jun 26, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | $20 → $30 | $13.72 | +118.66% | 5 | Jun 17, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $6.12 | +63.40% | 1 | May 18, 2026 | |
| ELMD Electromed | Reiterated: Buy | $38 → $40 | $27.25 | +46.79% | 2 | May 13, 2026 | |
| OPRX OptimizeRx | Reiterated: Buy | $11 → $10 | $7.29 | +37.17% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $32 → $36 | $22.40 | +60.71% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.4064 | +884.25% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 | $10.70 | +30.90% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.45 | +244.83% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.31 | +163.65% | 3 | Jan 21, 2026 |
Varex Imaging
Aug 10, 2026
Downgraded: Hold
Price Target: $18 → $19
Current: $18.49
Upside: +2.25%
LifeMD
Aug 6, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $3.05
Upside: +162.30%
InfuSystem Holdings
Aug 5, 2026
Rated: Buy
Price Target: $12 → $20
Current: $12.15
Upside: +64.61%
Exagen
Aug 5, 2026
Rated: Buy
Price Target: $8 → $12
Current: $7.03
Upside: +70.70%
Anika Therapeutics
Jul 30, 2026
Reiterated: Buy
Price Target: $18 → $21
Current: $20.99
Upside: +0.07%
Nutex Health
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $290
Current: $200.24
Upside: +44.83%
ClearPoint Neuro
Jun 17, 2026
Reiterated: Buy
Price Target: $20 → $30
Current: $13.72
Upside: +118.66%
Orchestra BioMed Holdings
May 18, 2026
Reiterated: Buy
Price Target: $10
Current: $6.12
Upside: +63.40%
Electromed
May 13, 2026
Reiterated: Buy
Price Target: $38 → $40
Current: $27.25
Upside: +46.79%
OptimizeRx
May 13, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $7.29
Upside: +37.17%
May 7, 2026
Upgraded: Buy
Price Target: $32 → $36
Current: $22.40
Upside: +60.71%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.4064
Upside: +884.25%
Feb 26, 2026
Downgraded: Hold
Price Target: $14
Current: $10.70
Upside: +30.90%
Feb 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.45
Upside: +244.83%
Jan 21, 2026
Reiterated: Buy
Price Target: $14
Current: $5.31
Upside: +163.65%